ValuEngine upgraded shares of Edap Tms S.A. (NASDAQ:EDAP) from a sell rating to a hold rating in a report issued on Friday.

Several other equities research analysts also recently weighed in on the company. Zacks Investment Research downgraded Edap Tms from a hold rating to a strong sell rating in a report on Tuesday, August 29th. HC Wainwright reissued a buy rating and issued a $6.50 price objective on shares of Edap Tms in a report on Friday, August 25th.

Edap Tms (NASDAQ EDAP) opened at 3.188 on Friday. The firm’s 50-day moving average is $2.95 and its 200-day moving average is $2.92. The stock’s market capitalization is $92.44 million. Edap Tms has a 52-week low of $2.25 and a 52-week high of $3.85.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings data on Wednesday, August 23rd. The medical equipment provider reported ($0.05) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.03). The firm had revenue of $10.40 million during the quarter, compared to analyst estimates of $10.00 million. Edap Tms had a negative net margin of 0.27% and a positive return on equity of 10.31%. Edap Tms’s revenue was up 13.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 earnings per share. Analysts predict that Edap Tms will post $0.01 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Edap Tms S.A. (EDAP) Upgraded to Hold at ValuEngine” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at

Hedge funds have recently bought and sold shares of the company. Virtu KCG Holdings LLC acquired a new stake in shares of Edap Tms in the second quarter valued at approximately $117,000. Essex Investment Management Co. LLC acquired a new stake in shares of Edap Tms in the second quarter valued at approximately $172,000. Hilton Capital Management LLC boosted its holdings in shares of Edap Tms by 43.1% in the second quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock valued at $274,000 after acquiring an additional 25,000 shares during the period. Finally, Archon Capital Management LLC acquired a new stake in shares of Edap Tms in the second quarter valued at approximately $2,474,000. 9.41% of the stock is owned by institutional investors and hedge funds.

Edap Tms Company Profile

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Stock Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related stocks with our FREE daily email newsletter.